Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.92 B2.34 B2.59 B2.19 B2.17 B 9.29 B Research & development ————— — Operating income 1.06 B2.25 B3.48 B2.03 B1.27 B 9.03 B Non-Operating Income, Total -437 M-1.72 B256 M31 M683 M -747 M Interest expense, net of interest capitalized 649 M418 M301 M249 M253 M 1.22 B Non-Operating Income, excl. Interest Expenses -828 M-1.17 B-84 M-102 M236 M -1.12 B Unusual income/expense -258 M-962 M39 M-116 M194 M -845 M Pretax income 396 M1.1 B3.47 B1.86 B1.4 B 7.83 B Equity in earnings ————— — Taxes 63 M209 M721 M435 M316 M 1.68 B Non-controlling/minority interest ————— — After tax other income/expense 44 M25 M65 M-118 M-5 M -33 M Net income before discontinued operations 333 M895 M2.75 B1.43 B1.08 B 6.15 B Discontinued operations ————— — Net income 333 M895 M2.75 B1.43 B1.08 B 6.15 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 333 M895 M2.75 B1.43 B1.08 B 6.15 B Basic earnings per share (Basic EPS) 0.411.13.391.751.37 7.62 Diluted earnings per share (Diluted EPS) 0.41.13.381.751.36 7.58 Average basic shares outstanding 821.13 M812.35 M809.6 M811.3 M790 M — Diluted shares outstanding 827.33 M815.48 M813.95 M815.98 M794 M — EBITDA 1.22 B2.41 B3.64 B2.18 B1.4 B 9.63 B EBIT 1.06 B2.25 B3.48 B2.03 B1.27 B 9.03 B Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 154 M158 M160 M151 M131 M 600 M